Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Michetti

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Helicobacter|March 3, 2009
Reduction of Helicobacter infection in IL-10-/- mice is dependent on CD4+ T cells but not on mast cellsDominique Velin, Daniel Bachmann, Hanifa Bouzourene, et al.
Swiss Medical Weekly|June 28, 2011
Treatment algorithm for moderate to severe ulcerative colitisMichael Manz, Pierre Michetti, Frank Seibold, et al.
Gastroenterologie Clinique Et Biologique|November 1, 2006
[De novo inflammatory bowel diseases after liver transplantation: description of four new cases and a review of the literature]Francis Vu, Michel Maillard, Manuel Pascual, et al.
Digestive Diseases (Basel, Switzerland)|February 5, 2003
Endoscopic interventions for preneoplastic and neoplastic lesions: mucosectomy, argon plasma coagulation, and photodynamic therapyMaria-Anna Ortner, Gian Dorta, André Louis Blum, et al.
European Journal of Gastroenterology & Hepatology|July 29, 2010
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazinePia Munkholm, Pierre Michetti, Chris S Probert, et al.
Digestion|February 3, 2004
Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in SwitzerlandFabiola Delcò, Pierre Michetti, Christoph Beglinger, et al.
Circulation Research|January 12, 2002
Influence of Helicobacter pylori infection during atherogenesis in vivo in miceFrançois Mach, Galina K Sukhova, Murielle Michetti, et al.
Plos One|May 18, 2018
Patient-reported healthcare expectations in inflammatory bowel diseasesValérie Pittet, Carla Vaucher, Florian Froehlich, et al.
Digestion|October 25, 2017
Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease PatientsCarole Rouiller-Braunschweig, Nicolas Fournier, Valérie Pittet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
Comment on "Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis"Sicheng Wen, Christian P Felley, Vera Kessler, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Helicobacter|March 3, 2009
Reduction of Helicobacter infection in IL-10-/- mice is dependent on CD4+ T cells but not on mast cellsDominique Velin, Daniel Bachmann, Hanifa Bouzourene, et al.
Swiss Medical Weekly|June 28, 2011
Treatment algorithm for moderate to severe ulcerative colitisMichael Manz, Pierre Michetti, Frank Seibold, et al.
Gastroenterologie Clinique Et Biologique|November 1, 2006
[De novo inflammatory bowel diseases after liver transplantation: description of four new cases and a review of the literature]Francis Vu, Michel Maillard, Manuel Pascual, et al.
Digestive Diseases (Basel, Switzerland)|February 5, 2003
Endoscopic interventions for preneoplastic and neoplastic lesions: mucosectomy, argon plasma coagulation, and photodynamic therapyMaria-Anna Ortner, Gian Dorta, André Louis Blum, et al.
European Journal of Gastroenterology & Hepatology|July 29, 2010
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazinePia Munkholm, Pierre Michetti, Chris S Probert, et al.
Digestion|February 3, 2004
Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in SwitzerlandFabiola Delcò, Pierre Michetti, Christoph Beglinger, et al.
Circulation Research|January 12, 2002
Influence of Helicobacter pylori infection during atherogenesis in vivo in miceFrançois Mach, Galina K Sukhova, Murielle Michetti, et al.
Plos One|May 18, 2018
Patient-reported healthcare expectations in inflammatory bowel diseasesValérie Pittet, Carla Vaucher, Florian Froehlich, et al.
Digestion|October 25, 2017
Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease PatientsCarole Rouiller-Braunschweig, Nicolas Fournier, Valérie Pittet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
Comment on "Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis"Sicheng Wen, Christian P Felley, Vera Kessler, et al.
Pageof 15